224 related articles for article (PubMed ID: 24860782)
1. Mysteries of TGF-β Paradox in Benign and Malignant Cells.
Zhang Q; Yu N; Lee C
Front Oncol; 2014; 4():94. PubMed ID: 24860782
[TBL] [Abstract][Full Text] [Related]
2. Vicious cycle of TGF-β signaling in tumor progression and metastasis.
Zhang Q; Yu N; Lee C
Am J Clin Exp Urol; 2014; 2(2):149-55. PubMed ID: 25374917
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
[TBL] [Abstract][Full Text] [Related]
4. Tgf-beta induced Erk phosphorylation of smad linker region regulates smad signaling.
Hough C; Radu M; Doré JJ
PLoS One; 2012; 7(8):e42513. PubMed ID: 22880011
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW
Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells.
Ghayor C; Rey A; Caverzasio J
Bone; 2005 Jan; 36(1):93-100. PubMed ID: 15664007
[TBL] [Abstract][Full Text] [Related]
8. The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: A "TGF-β paradox".
Zhang Z; Auyeung KK; Sze SC; Zhang S; Yung KK; Ko JK
Phytomedicine; 2020 Mar; 68():153177. PubMed ID: 32106002
[TBL] [Abstract][Full Text] [Related]
9. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
[TBL] [Abstract][Full Text] [Related]
10. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
Lee YH; Schiemann WP
Breast Cancer Manag; 2014; 3(1):73-85. PubMed ID: 25904986
[TBL] [Abstract][Full Text] [Related]
12. Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.
Arnott JA; Zhang X; Sanjay A; Owen TA; Smock SL; Rehman S; DeLong WG; Safadi FF; Popoff SN
Bone; 2008 May; 42(5):871-85. PubMed ID: 18314002
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway.
Cabello-Verrugio C; Córdova G; Vial C; Zúñiga LM; Brandan E
Cell Signal; 2011 Feb; 23(2):449-57. PubMed ID: 20965247
[TBL] [Abstract][Full Text] [Related]
14. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.
Ungefroren H; Witte D; Fiedler C; Gädeken T; Kaufmann R; Lehnert H; Gieseler F; Rauch BH
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261154
[TBL] [Abstract][Full Text] [Related]
15. TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways.
Zhao Y; Ma J; Fan Y; Wang Z; Tian R; Ji W; Zhang F; Niu R
Mol Oncol; 2018 Mar; 12(3):305-321. PubMed ID: 29215776
[TBL] [Abstract][Full Text] [Related]
16. The transforming growth factor beta 1/SMAD signaling pathway involved in human chronic myeloid leukemia.
Su E; Han X; Jiang G
Tumori; 2010; 96(5):659-66. PubMed ID: 21302608
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor.
Finlay GA; Thannickal VJ; Fanburg BL; Paulson KE
J Biol Chem; 2000 Sep; 275(36):27650-6. PubMed ID: 10862759
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta in benign and malignant prostate.
Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
Räsänen K; Vaheri A
J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
[TBL] [Abstract][Full Text] [Related]
20. miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer.
Luo Y; Wu J; Wu Q; Li X; Wu J; Zhang J; Rong X; Rao J; Liao Y; Bin J; Huang N; Liao W
Mol Ther; 2019 Jun; 27(6):1166-1182. PubMed ID: 30879950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
